This meeting will showcase trailblazing approaches in the design and engineering of novel biologic modalities as linked to their pre-clinical development and selected early outcomes in the clinic.
the topics covered will engage discussions around: antibody-based protein degraders; next-generation antibody drug conjugate technologies; precision biologics; increasing accessibility of antibody drugs on a global scale; advances in combination biology and modalities
1.
Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer
2.
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
3.
MGRS Relapse-Free Survival Better With Maintenance Therapy
4.
New protein target discovered for childhood medulloblastomas
5.
The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.
1.
Essential Updates in Hematology in Daily Practice
2.
Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics
3.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
4.
Potential of Device-Assisted Therapy in Non-Muscle-Invasive Bladder Cancer
5.
The Silent Danger of Hematoma: How to Identify and Treat This Potentially Serious Condition
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Understanding Blood Disorders and Their Diagnosis
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
Recommended News For You
1.
High resolution ultrasound could enable faster prostate cancer diagnosis
2.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
3.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
4.
New research demonstrates a method for screening people at high risk for pancreatic cancer.
5.
Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing
Conferences That Might Interest You
Recommended Articles For You
1.
Multi-Cancer Risk Stratification Through Precision Screening
2.
The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis
3.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
4.
Giant Sebaceous Cyst of the Scalp Mimicking a Soft Tissue Tumor: A Case Study
5.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
Boost Your Knowledge With These Quizzes
1.
Quiz on Unlocking the Cycle: Hormonal Insights into Menstrual Disorders
2.
Assessing and Counseling Patients on Health Risks: A Quiz for Healthcare Professionals
3.
Quiz On Importance of Anaphylaxis
4.
Quiz on Antioxidant Therapies in ALS
5.
Quiz on Advances in Continuous Glucose Monitoring Systems: How Up-to-Date Are You?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation